Iron chelation is hypothesized to have neuroprotective effects in reducing damaging ROS, inhibiting the setting of A and tau pathology, and decreasing levels of brain iron [106, 107]
Fatigue can often be managed by ensuring adequate rest and maintaining gentle physical activity where possible
Similarly, semaglutide has shown potential in managing OSA through significant weight reduction
Other reasons could include travel, convenience and, as Spates Atkinson mentioned, self-expression
Below is a quick overview of the most common scenarios
A quanto gi sul mercato farmacologico, come accennato in un precedente articolo (vedi), buone sono le prospettive riguardo ad una nuova molecola probabilmente in arrivo (dopo debita approvazione da parte degli Organi di vigilanza) nei prossimi 6-12 mesi